Annual Net Income
-$22.29 M
+$6.73 M+23.20%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual net profit is -$22.29 million, with the most recent change of +$6.73 million (+23.20%) on December 31, 2023.
- During the last 3 years, CAPR annual net income has fallen by -$8.63 million (-63.19%).
- CAPR annual net income is now -1016.65% below its all-time high of $2.43 million, reached on December 31, 2017.
Performance
CAPR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$12.56 M
-$1.56 M-14.15%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly net profit is -$12.56 million, with the most recent change of -$1.56 million (-14.15%) on September 30, 2024.
- Over the past year, CAPR quarterly net income has dropped by -$1.56 million (-14.15%).
- CAPR quarterly net income is now -202.04% below its all-time high of $12.31 million, reached on December 31, 2017.
Performance
CAPR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$34.11 M
-$6.17 M-22.06%
September 30, 2024
Summary
- As of February 7, 2025, CAPR TTM net profit is -$34.11 million, with the most recent change of -$6.17 million (-22.06%) on September 30, 2024.
- Over the past year, CAPR TTM net income has dropped by -$6.17 million (-22.06%).
- CAPR TTM net income is now -1502.95% below its all-time high of $2.43 million, reached on December 31, 2017.
Performance
CAPR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CAPR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.2% | -14.2% | -22.1% |
| 3 y3 years | -63.2% | -62.6% | -17.6% |
| 5 y5 years | -46.7% | -62.6% | -17.6% |
CAPR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.3% | +23.2% | -1547.6% | at low | -70.4% | at low |
| 5 y | 5-year | -191.7% | +23.2% | -1547.6% | at low | -373.3% | at low |
| alltime | all time | -1016.6% | +23.2% | -202.0% | at low | -1503.0% | at low |
Capricor Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.56 M(+14.2%) | -$34.11 M(+22.1%) |
| Jun 2024 | - | -$11.00 M(+12.3%) | -$27.95 M(+14.9%) |
| Mar 2024 | - | -$9.79 M(+1185.1%) | -$24.31 M(+9.1%) |
| Dec 2023 | -$22.29 M(-23.2%) | -$762.10 K(-88.1%) | -$22.29 M(-23.8%) |
| Sep 2023 | - | -$6.39 M(-13.2%) | -$29.25 M(+0.1%) |
| Jun 2023 | - | -$7.37 M(-5.2%) | -$29.23 M(+0.9%) |
| Mar 2023 | - | -$7.77 M(+0.6%) | -$28.97 M(-0.2%) |
| Dec 2022 | -$29.02 M(+44.9%) | -$7.72 M(+21.2%) | -$29.02 M(+5.6%) |
| Sep 2022 | - | -$6.37 M(-10.4%) | -$27.49 M(+9.7%) |
| Jun 2022 | - | -$7.11 M(-9.1%) | -$25.05 M(+10.4%) |
| Mar 2022 | - | -$7.82 M(+26.3%) | -$22.69 M(+13.3%) |
| Dec 2021 | -$20.02 M(+46.6%) | -$6.19 M(+57.4%) | -$20.02 M(+11.2%) |
| Sep 2021 | - | -$3.93 M(-17.2%) | -$18.01 M(+0.1%) |
| Jun 2021 | - | -$4.75 M(-7.8%) | -$17.99 M(+7.6%) |
| Mar 2021 | - | -$5.15 M(+23.3%) | -$16.72 M(+22.5%) |
| Dec 2020 | -$13.66 M(+78.7%) | -$4.18 M(+6.8%) | -$13.66 M(+24.7%) |
| Sep 2020 | - | -$3.91 M(+12.2%) | -$10.95 M(+26.6%) |
| Jun 2020 | - | -$3.48 M(+67.1%) | -$8.64 M(+19.9%) |
| Mar 2020 | - | -$2.08 M(+41.9%) | -$7.21 M(-5.7%) |
| Dec 2019 | -$7.64 M(-49.7%) | -$1.47 M(-8.5%) | -$7.64 M(-19.0%) |
| Sep 2019 | - | -$1.61 M(-21.5%) | -$9.43 M(-21.1%) |
| Jun 2019 | - | -$2.05 M(-18.8%) | -$11.96 M(-14.8%) |
| Mar 2019 | - | -$2.52 M(-22.7%) | -$14.04 M(-7.6%) |
| Dec 2018 | -$15.19 M(-724.8%) | -$3.26 M(-21.2%) | -$15.19 M(-4160.7%) |
| Sep 2018 | - | -$4.14 M(+0.3%) | $374.10 K(-78.9%) |
| Jun 2018 | - | -$4.12 M(+12.3%) | $1.78 M(-26.8%) |
| Mar 2018 | - | -$3.67 M(-129.8%) | $2.43 M(-0.2%) |
| Dec 2017 | $2.43 M(-112.9%) | $12.31 M(-549.9%) | $2.43 M(-116.9%) |
| Sep 2017 | - | -$2.73 M(-21.2%) | -$14.39 M(-15.3%) |
| Jun 2017 | - | -$3.47 M(-5.3%) | -$16.99 M(-6.7%) |
| Mar 2017 | - | -$3.67 M(-18.8%) | -$18.21 M(-3.2%) |
| Dec 2016 | -$18.81 M(+46.3%) | -$4.52 M(-15.3%) | -$18.81 M(+6.6%) |
| Sep 2016 | - | -$5.33 M(+13.7%) | -$17.63 M(+15.9%) |
| Jun 2016 | - | -$4.69 M(+9.9%) | -$15.21 M(+11.5%) |
| Mar 2016 | - | -$4.27 M(+27.5%) | -$13.65 M(+6.1%) |
| Dec 2015 | -$12.86 M(+106.8%) | -$3.35 M(+14.9%) | -$12.86 M(+12.4%) |
| Sep 2015 | - | -$2.91 M(-6.8%) | -$11.44 M(+13.6%) |
| Jun 2015 | - | -$3.12 M(-10.2%) | -$10.07 M(+18.7%) |
| Mar 2015 | - | -$3.48 M(+80.3%) | -$8.48 M(+36.4%) |
| Dec 2014 | -$6.22 M(-30.1%) | -$1.93 M(+24.9%) | -$6.22 M(-27.7%) |
| Sep 2014 | - | -$1.54 M(+0.7%) | -$8.59 M(-0.0%) |
| Jun 2014 | - | -$1.53 M(+26.7%) | -$8.59 M(-1.0%) |
| Mar 2014 | - | -$1.21 M(-71.9%) | -$8.69 M(-2.3%) |
| Dec 2013 | -$8.89 M(+329.3%) | -$4.30 M(+178.6%) | -$8.89 M(+79.0%) |
| Sep 2013 | - | -$1.55 M(-4.9%) | -$4.97 M(+24.5%) |
| Jun 2013 | - | -$1.62 M(+14.6%) | -$3.99 M(+46.8%) |
| Mar 2013 | - | -$1.42 M(+272.7%) | -$2.72 M(+31.2%) |
| Dec 2012 | -$2.07 M | -$380.20 K(-32.9%) | -$2.07 M(-38.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$566.20 K(+60.4%) | -$3.36 M(-14.7%) |
| Jun 2012 | - | -$352.90 K(-54.3%) | -$3.93 M(-11.8%) |
| Mar 2012 | - | -$771.90 K(-53.6%) | -$4.46 M(-8.7%) |
| Dec 2011 | -$4.88 M(-19.0%) | -$1.66 M(+45.5%) | -$4.88 M(+21.6%) |
| Sep 2011 | - | -$1.14 M(+29.9%) | -$4.02 M(-14.2%) |
| Jun 2011 | - | -$880.50 K(-26.4%) | -$4.68 M(-11.6%) |
| Mar 2011 | - | -$1.20 M(+50.3%) | -$5.30 M(-12.2%) |
| Dec 2010 | -$6.03 M(-23.4%) | -$795.70 K(-56.0%) | -$6.03 M(-11.3%) |
| Sep 2010 | - | -$1.81 M(+21.1%) | -$6.80 M(-3.1%) |
| Jun 2010 | - | -$1.49 M(-22.6%) | -$7.02 M(-12.5%) |
| Mar 2010 | - | -$1.93 M(+23.4%) | -$8.03 M(+1.9%) |
| Dec 2009 | -$7.87 M(-40.1%) | -$1.57 M(-22.8%) | -$7.87 M(-15.2%) |
| Sep 2009 | - | -$2.03 M(-18.9%) | -$9.28 M(-12.2%) |
| Jun 2009 | - | -$2.50 M(+40.5%) | -$10.57 M(-10.8%) |
| Mar 2009 | - | -$1.78 M(-40.2%) | -$11.85 M(-9.7%) |
| Dec 2008 | -$13.13 M(+27.5%) | -$2.97 M(-10.4%) | -$13.13 M(+3.6%) |
| Sep 2008 | - | -$3.32 M(-12.1%) | -$12.67 M(-14.9%) |
| Jun 2008 | - | -$3.78 M(+23.5%) | -$14.90 M(+18.2%) |
| Mar 2008 | - | -$3.06 M(+21.5%) | -$12.60 M(+22.3%) |
| Dec 2007 | -$10.30 M(+299.0%) | -$2.52 M(-54.6%) | -$10.30 M(+22.8%) |
| Sep 2007 | - | -$5.55 M(+274.8%) | -$8.39 M(+129.7%) |
| Jun 2007 | - | -$1.48 M(+95.5%) | -$3.65 M(+67.5%) |
| Mar 2007 | - | -$757.40 K(+26.1%) | -$2.18 M(+52.5%) |
| Dec 2006 | -$2.58 M(>+9900.0%) | -$600.40 K(-26.2%) | -$1.43 M(+70.9%) |
| Sep 2006 | - | -$813.70 K(+8941.1%) | -$837.00 K(+3034.8%) |
| Jun 2006 | - | -$9000.00(+25.0%) | -$26.70 K(+29.6%) |
| Mar 2006 | - | -$7200.00(+1.4%) | -$20.60 K(+9.6%) |
| Dec 2005 | -$18.90 K(+4.4%) | -$7100.00(+108.8%) | -$18.80 K(-10.5%) |
| Sep 2005 | - | -$3400.00(+17.2%) | -$21.00 K(-0.5%) |
| Jun 2005 | - | -$2900.00(-46.3%) | -$21.10 K(0.0%) |
| Mar 2005 | - | -$5400.00(-41.9%) | -$21.10 K(+15.9%) |
| Dec 2004 | -$18.10 K(+11.7%) | -$9300.00(+165.7%) | -$18.20 K(+27.3%) |
| Sep 2004 | - | -$3500.00(+20.7%) | -$14.30 K(+31.2%) |
| Jun 2004 | - | -$2900.00(+16.0%) | -$10.90 K(-27.3%) |
| Mar 2004 | - | -$2500.00(-53.7%) | -$15.00 K(-7.4%) |
| Dec 2003 | -$16.20 K(+3.8%) | -$5400.00(+5300.0%) | -$16.20 K(+11.0%) |
| Sep 2003 | - | -$100.00(-98.6%) | -$14.60 K(-36.8%) |
| Jun 2003 | - | -$7000.00(+89.2%) | -$23.10 K(-9.4%) |
| Mar 2003 | - | -$3700.00(-2.6%) | -$25.50 K(+63.5%) |
| Dec 2002 | -$15.60 K(-30.0%) | -$3800.00(-55.8%) | -$15.60 K(+6.8%) |
| Sep 2002 | - | -$8600.00(-8.5%) | -$14.60 K(+36.4%) |
| Jun 2002 | - | -$9400.00(-251.6%) | -$10.70 K(+55.1%) |
| Mar 2002 | - | $6200.00(-321.4%) | -$6900.00(-68.9%) |
| Dec 2001 | -$22.30 K(-38.9%) | -$2800.00(-40.4%) | -$22.20 K(+14.4%) |
| Sep 2001 | - | -$4700.00(-16.1%) | -$19.40 K(+32.0%) |
| Jun 2001 | - | -$5600.00(-38.5%) | -$14.70 K(+61.5%) |
| Mar 2001 | - | -$9100.00 | -$9100.00 |
| Dec 2000 | -$36.50 K(>+9900.0%) | - | - |
| Dec 1999 | -$200.00 | - | - |
FAQ
- What is Capricor Therapeutics annual net profit?
- What is the all time high annual net income for Capricor Therapeutics?
- What is Capricor Therapeutics annual net income year-on-year change?
- What is Capricor Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly net income year-on-year change?
- What is Capricor Therapeutics TTM net profit?
- What is the all time high TTM net income for Capricor Therapeutics?
- What is Capricor Therapeutics TTM net income year-on-year change?
What is Capricor Therapeutics annual net profit?
The current annual net income of CAPR is -$22.29 M
What is the all time high annual net income for Capricor Therapeutics?
Capricor Therapeutics all-time high annual net profit is $2.43 M
What is Capricor Therapeutics annual net income year-on-year change?
Over the past year, CAPR annual net profit has changed by +$6.73 M (+23.20%)
What is Capricor Therapeutics quarterly net profit?
The current quarterly net income of CAPR is -$12.56 M
What is the all time high quarterly net income for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly net profit is $12.31 M
What is Capricor Therapeutics quarterly net income year-on-year change?
Over the past year, CAPR quarterly net profit has changed by -$1.56 M (-14.15%)
What is Capricor Therapeutics TTM net profit?
The current TTM net income of CAPR is -$34.11 M
What is the all time high TTM net income for Capricor Therapeutics?
Capricor Therapeutics all-time high TTM net profit is $2.43 M
What is Capricor Therapeutics TTM net income year-on-year change?
Over the past year, CAPR TTM net profit has changed by -$6.17 M (-22.06%)